Besides, the induction of phase II detoxification enzymes HO-1 and glutamate-Lcysteine ligase catalytic subunit (GCLC) plays an antioxidant role in the Nrf2 pathway in NAFLD (208). The gene discussed is HMOX1; the disease is metabolic dysfunction-associated steatotic liver disease.